Callahan Advisors, LLC Abbott Laboratories Transaction History

Callahan Advisors, LLC

  • $929 Million
  • Q2 2024

A detailed history of Callahan Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Callahan Advisors, LLC holds 73,155 shares of ABT stock, worth $8.24 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
73,155
Previous 73,902 1.01%
Holding current value
$8.24 Million
Previous $8.4 Million 9.5%
% of portfolio
0.82%
Previous 0.91%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$100.73 - $112.44 $75,245 - $83,992
-747 Reduced 1.01%
73,155 $7.6 Million
Q1 2024

Apr 24, 2024
SELL
$109.52 - $120.96 $645,729 - $713,180
-5,896 Reduced 7.39%
73,902 $8.4 Million
Q4 2023

Jan 24, 2024
SELL
$90.19 - $110.4 $188,406 - $230,625
-2,089 Reduced 2.55%
79,798 $8.78 Million
Q3 2023

Oct 23, 2023
SELL
$95.53 - $114.62 $738,255 - $885,783
-7,728 Reduced 8.62%
81,887 $7.93 Million
Q2 2023

Jul 31, 2023
SELL
$100.78 - $112.29 $210,831 - $234,910
-2,092 Reduced 2.28%
89,615 $9.77 Million
Q1 2023

Apr 28, 2023
SELL
$96.86 - $114.01 $213,673 - $251,506
-2,206 Reduced 2.35%
91,707 $9.29 Million
Q4 2022

Feb 03, 2023
SELL
$95.06 - $111.52 $18,346 - $21,523
-193 Reduced 0.21%
93,913 $10.3 Million
Q3 2022

Oct 27, 2022
SELL
$96.76 - $112.03 $113,886 - $131,859
-1,177 Reduced 1.24%
94,106 $9.11 Million
Q2 2022

Jul 29, 2022
SELL
$102.07 - $123.37 $23,986 - $28,991
-235 Reduced 0.25%
95,283 $10.4 Million
Q1 2022

Apr 27, 2022
SELL
$114.02 - $139.04 $383,221 - $467,313
-3,361 Reduced 3.4%
95,518 $11.3 Million
Q4 2021

Feb 08, 2022
BUY
$115.53 - $141.46 $196,863 - $241,047
1,704 Added 1.75%
98,879 $13.9 Million
Q3 2021

Nov 03, 2021
SELL
$116.66 - $129.06 $115,960 - $128,285
-994 Reduced 1.01%
97,175 $11.5 Million
Q2 2021

Aug 11, 2021
SELL
$105.79 - $124.53 $373,121 - $439,217
-3,527 Reduced 3.47%
98,169 $11.4 Million
Q1 2021

Apr 21, 2021
SELL
$108.84 - $128.23 $209,299 - $246,586
-1,923 Reduced 1.86%
101,696 $12.2 Million
Q4 2020

Jan 20, 2021
SELL
$105.0 - $114.42 $293,790 - $320,147
-2,798 Reduced 2.63%
103,619 $11.3 Million
Q3 2020

Oct 26, 2020
SELL
$91.64 - $111.29 $30,791 - $37,393
-336 Reduced 0.31%
106,417 $11.6 Million
Q2 2020

Jul 17, 2020
BUY
$76.57 - $98.0 $55,436 - $70,952
724 Added 0.68%
106,753 $9.76 Million
Q1 2020

Apr 06, 2020
SELL
$62.82 - $91.86 $275,277 - $402,530
-4,382 Reduced 3.97%
106,029 $8.37 Million
Q4 2019

Jan 21, 2020
SELL
$78.51 - $87.4 $816,504 - $908,960
-10,400 Reduced 8.61%
110,411 $9.59 Million
Q3 2019

Oct 21, 2019
SELL
$81.84 - $88.74 $286,358 - $310,501
-3,499 Reduced 2.81%
120,811 $10.1 Million
Q2 2019

Jul 17, 2019
SELL
$72.88 - $85.0 $45,841 - $53,465
-629 Reduced 0.5%
124,310 $10.5 Million
Q1 2019

Apr 22, 2019
BUY
$66.22 - $80.06 $203,494 - $246,024
3,073 Added 2.52%
124,939 $9.99 Million
Q4 2018

Jan 24, 2019
BUY
$65.56 - $74.27 $68,313 - $77,389
1,042 Added 0.86%
121,866 $8.82 Million
Q3 2018

Oct 15, 2018
BUY
$60.81 - $73.36 $623,180 - $751,793
10,248 Added 9.27%
120,824 $8.86 Million
Q2 2018

Jul 19, 2018
BUY
$57.57 - $63.54 $153,596 - $169,524
2,668 Added 2.47%
110,576 $6.74 Million
Q1 2018

Apr 30, 2018
BUY
$56.27 - $63.62 $131,165 - $148,298
2,331 Added 2.21%
107,908 $6.47 Million
Q4 2017

Jan 31, 2018
BUY
$53.68 - $57.47 $248,592 - $266,143
4,631 Added 4.59%
105,577 $6.03 Million
Q3 2017

Oct 26, 2017
BUY
$48.06 - $53.64 $4.85 Million - $5.41 Million
100,946
100,946 $5.39 Million

Others Institutions Holding ABT

# of Institutions
3,138
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Callahan Advisors, LLC Portfolio

Follow Callahan Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email